FiltersReset Filters

With box warnings

Without box warnings

Branded

Generic

20 results

alhemo
(concizumab)
Novo Nordisk
Usage: Alhemo is indicated for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients aged 12 and older with hemophilia A (factor VIII deficiency with inhibitors) and hemophilia B (factor IX deficiency with inhibitors).
fiasp
(insulin aspart injection)
Novo Nordisk
Usage: FIASP is indicated for improving glycemic control in both adult and pediatric patients with diabetes mellitus.
levemir
(insulin detemir)
Novo Nordisk
Usage: LEVEMIR is indicated for improving glycemic control in adults and pediatric patients with diabetes mellitus. However, it is not recommended for treating diabetic ketoacidosis.
macrilen
(Macimorelin acetate)
Novo Nordisk
Usage: MACRILEN is used for diagnosing adult growth hormone deficiency (AGHD). Its safety and diagnostic effectiveness in individuals with a body mass index (BMI) greater than 40 kg/m² have not been established.
norditropin
(somatropin)
Novo Nordisk
Usage: NORDITROPIN is indicated for pediatric patients with growth failure from inadequate growth hormone secretion, short stature due to Noonan or Turner syndrome, short stature born SGA, Idiopathic Short Stature, and Prader-Willi syndrome. For adults, it is used to replace endogenous growth hormone in those with deficiency.
novolog - insulin aspart injection, solution
(Water Injection)
Novo Nordisk
novolog mix 70/30- insulin aspart injection, suspension
(Insulin Aspart)
Novo Nordisk
ozempic
(semaglutide)
Novo Nordisk
Usage: OZEMPIC is indicated as an adjunct to diet and exercise for improving glycemic control in adults with type 2 diabetes. It also reduces the risk of major adverse cardiovascular events and helps in preventing kidney disease progression in patients with type 2 diabetes and chronic kidney disease.
rebinyn - coagulation factor ix recombinant, glycopegylated
(Coagulation Factor Ix Recombinant, Glycopegylated)
Novo Nordisk
rivfloza
(nedosiran)
Novo Nordisk
Usage: RIVFLOZA is indicated for lowering urinary oxalate levels in children aged 2 years and older and adults with primary hyperoxaluria type 1 (PH1) who have relatively preserved kidney function (eGFR ≥30 mL/min/1.73 m²).

Novo Nordisk drugs

alhemo

fiasp

levemir

macrilen

norditropin

novolog - insulin aspart injection, solution

novolog mix 70/30- insulin aspart injection, suspension

ozempic

rebinyn - coagulation factor ix recombinant, glycopegylated

rivfloza